Proapoptotic effects of Tau cleavage product generated by caspase-3

Neurobiology of Disease

Volumn 8, Issue 1, 2001, Pages 162-172

  Chung, Chul Woong ^a   Song, Yu Hyun ^a   Kim, In Ki ^a   Yoon, Won Joo ^b   Ryu, Bo Rum ^b   Jo, Dong Gyu ^a   Woo, Ha Na ^a   Kwon, Yun Kyong ^a   Kim, Hyun Hee ^a   Gwag, Byoung Joo ^b   Mook Jung, In Hee ^b   Jung, Yong Keun ^a,c  

^a Korea National Institute of Health   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALPAIN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; COMPLEMENTARY DNA; GENE PRODUCT; INTERLEUKIN 1BETA CONVERTING ENZYME; KETONE DERIVATIVE; MUTANT PROTEIN; PROTEIN ANTIBODY; STAUROSPORINE; TAU PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA LIBRARY; ENZYME SUBSTRATE; GENE OVEREXPRESSION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0035116325     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0335     Document Type: Article

References (63)

1. Human ICE/CED-3 protease nomenclature
2. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
3. Abnormal Tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
4. Functional organization of microtubuleassociated protein Tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro
5. Tau cleavage and dephosphorylation in cerebella granule neurons undergoing apoptosis
6. Role of tau in the polymerization of peptides from beta-amyloid precursor protein
7. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
8. Modulating apoptosis: Current applications and prospects for future drug development
9. Involvement of an ICE-like protease in Fas-mediated apoptosis
10. A caspase activated DNase that degraded DNA during apoptosis, and its inhibitor ICAD
11. Proapoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism
12. Prevention of vertebrate neuronal death by the crmA gene
13. Involvement of caspase in proteolytic cleavage of Alzheimer's amyloid precursor protein and amyloidogenic A beta peptide formation
14. Tau protein and the neurofibrillary pathology of Alzheimer's disease
15. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
16. Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis
17. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta peptide
18. Differential requirement for caspase 9 in apoptotic pathways in vivo
19. DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease
20. Microtubule organization and dynamics dependent on microtubule-associated proteins
21. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
22. Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites
23. Carboxyl-terminal fragment of β-amyloid precursor protein bind to microtubules and the associated protein Tau
24. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis
25. G3-(lodoacetamido)-benzoylurea: A novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells
26. Suppression of interleukin-1 beta-converting enzyme-mediated cell death by insulin-like growth factor
27. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease
28. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease
29. The carboxyl third of tau is tightly bound to paired helical filaments
30. Caspase-3-generated fragment of gelsolin: Effect of morphological change in apoptosis
31. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
32. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
33. The microtubule-binding domain of tau protein
34. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain
35. Phosphorylation of tau in situ: Inhibition of calcium-dependent proteolysis
36. DFF, a heterodimeric protein that functions downstream of caspse-3 to trigger DNA fragmentation during apoptosis
37. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro
38. Caspase-12 mediates endoplasmic reticulum-specific apoptosis and cytotoxicity by amyloid-β
39. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
40. Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures
41. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament
42. Truncated tau protein as a new marker for Alzheimer's disease
43. Apoptosis and autoimmune disease
44. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
45. Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain
46. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration")
47. Reactivating kinase/p38 phosphorylates tau protein in vitro
48. Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates tau protein
49. The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alter their interaction with the extracellular matrix
50. Caspases as treatment targets in stroke and neurodegenerative disease
51. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease
52. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
53. Apoptosis in neurodegenerative diseases: The role of mitochondria
54. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes
55. Caspases: Enemies within
56. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport
57. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein
58. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase
59. Participation of presenilin 2 in apoptosis enhanced basal activity confered by n Alzheimer mutation
60. Protein anatomy: C-tail region of human Tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro
61. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
62. Tumor radiosensitivity and apoptosis
63. Increased interleukin-1 beta converting enzyme expression activity in Alzheimer disease